Cataract Senile, Epiretinal Membrane
Conditions
Keywords
Metamorphopsia, Epiretinal membrane, Vitrectomy
Brief summary
This study evaluates the safety and efficacy simultaneous, trans-conjunctival, 25-Gauge vitrectomy and phacoemulsification with intraocular lens implant in patients with metamorphopsia and visual impairment due to idiopathic epiretinal membrane and cataract. All 30 patients recruited underwent complete ocular examination, visual acuity measurement with ETDRS, metamorphopsia assessment with M-Charts and Metamorphometry® and foveal thickness evaluation by sd-OCT preoperatively, at 30, 90, 180 days postoperatively.
Interventions
PROCEDUREPhacoemulsification, intraocular lens implant, vitrectomy.
Cataract extraction, intraocular lens implant, vitrectomy, epiretinal membrane and inner limiting retinal membrane peeling.
Sponsors
Clinica Oculistica dell'Università di Torino
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
55 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* age \> 55 years * visual acuity ≤ 20/40 * idiopathic epiretinal membrane * cataract * Amsler test positive for metamorphopsia.
Exclusion criteria
* previous ocular interventions * other ocular diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Metamorphopsia | Change in metamorphopsia from baseline at 180 days. | Change in spatial degree of distortion perception |
| Visual Acuity | Change in visual acuity from baseline at 180 days | Change in LogMAR visual acuity |
| Area of central scotoma | Change in area of central scotoma from baseline at 180 days | Change in area, in square pixel, of central scotoma |
| Central fovea thickness | Change in fovea thickness from baseline at 180 days | Change in fovea thickness in µm at the Sd OCT |
Outcome results
None listed